advances a culture of life in health care, empowering Catholics to act in charity, solidarity, and community with their fellow Christians, manage their health care, disentangle themselves from the ACA Individual Mandate, and truly experience Christian caring through the blessing of Samaritan Ministries International.
The Curos Port Protector market approval is a significant milestone toward the success of our company," Bob Rogers, Chief Executive Officer of Ivera Medical said.
Ivera Medical manufactures and sells the Curos Port Protector, a passive disinfection cap which disinfects and then guards luer activated swabbable valves against contamination between venous accesses to kill the organisms associated with catheter-related bloodstream infections.
The licensing agreement between BD and Ivera broadens our existing patent applications and removes potential patent issues so we can move forward with the worldwide marketing and sales of the Curos Port Protector," Jack Saladow, Ivera Vice President of Marketing and Sales said.
New Patent for Curos Disinfecting Port Protectors to be issued June 26, 2012 by USPTO
SAN DIEGO, June 7, 2012 /PRNewswire/ -- Ivera Medical Corporation, a company that manufactures, markets, and sells the Curos Disinfecting Port Protector, a device that disinfects and protects the entry port on needleless valves used with intravenous lines, categorically denies all claims made by Catheter Connections in their recent legal filings against Ivera.